Literature DB >> 21439762

A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit.

Donald M Arnold1, Francois Lauzier, Heather Whittingham, Qi Zhou, Mark A Crowther, Ellen McDonald, Deborah J Cook.   

Abstract

PURPOSE: The purpose of this study is to determine the effect of a multifaceted behavior-change strategy on inappropriate use of frozen plasma (FP) transfusions in the intensive care unit (ICU).
MATERIALS AND METHODS: A prospective, time-series study was conducted in a 15-bed medical-surgical ICU in 3 phases: (1) baseline observation; (2) educational campaign, audit and feedback to prescribers, and implementation of an FP request form; and (3) FP request form only. Independently, in triplicate and blinded to study phase, appropriateness of each FP request was adjudicated based on published guidelines and clinical context.
RESULTS: Over the 15-month study period, 626 FP transfusions (210 FP requests) were administered to 88 patients. Inappropriate FP requests decreased slightly from phases I to III (60% vs 46%; P = .09), FP requests that were consistent with the guidelines did not change (23% vs 22%; P = .86), and FP requests that were appropriate for the ICU yet inconsistent with the guidelines increased (17% vs 32%; P = .04). Although uptake of the FP request form decreased in phase III, it was associated with fewer inappropriate transfusions.
CONCLUSIONS: The behavior-change strategy modestly improved appropriate use of FP transfusions in the ICU. Improving FP request form accuracy, completeness, and compliance may be required to achieve maximum effect and ensure sustainability.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21439762     DOI: 10.1016/j.jcrc.2011.02.005

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

1.  Identification of Clinically Meaningful Plasma Transfusion Subgroups Using Unsupervised Random Forest Clustering.

Authors:  Che Ngufor; Matthew A Warner; Dennis H Murphree; Hongfang Liu; Rickey Carter; Curtis B Storlie; Daryl J Kor
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Evaluation of RBC Transfusion Practice in Adult ICUs and the Effect of Restrictive Transfusion Protocols on Routine Care.

Authors:  Kevin P Seitz; Jonathan E Sevransky; Greg S Martin; John D Roback; David J Murphy
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 3.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?

Authors:  Hunter B Moore; Robert D Winfield; Mayuki Aibiki; Matthew D Neal
Journal:  Shock       Date:  2017-08       Impact factor: 3.454

Review 4.  Prophylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?

Authors:  Klaus Görlinger; Fuat H Saner
Journal:  BMC Anesthesiol       Date:  2015-06-09       Impact factor: 2.217

5.  Plasma in the PICU: why and when should we transfuse?

Authors:  Sonia Labarinas; Delphine Arni; Oliver Karam
Journal:  Ann Intensive Care       Date:  2013-06-02       Impact factor: 6.925

6.  Audit and feedback to improve laboratory test and transfusion ordering in critical care: a systematic review.

Authors:  Madison Foster; Justin Presseau; Nicola McCleary; Kelly Carroll; Lauralyn McIntyre; Brian Hutton; Jamie Brehaut
Journal:  Implement Sci       Date:  2020-06-19       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.